A new study by researchers from the University of Florence may lead to the development of vaccines that can protect from hundreds of strains of meningococcal disease, the most frequent causes of bacterial meningitis.
Inflammation of the membranes of the brain and spinal cord - bacterial meningitis can lead to brain damage and death, existing vaccines against meningococcus In cannot protect from all 300 strains of the virus.
Scientists have invented a 54 bioengineering immunogen, which can induce an immune response, and tested them on laboratory mice. The test identified eight immunogens that protects against meningitis caused by antibodies protected against a variety of strains of the virus.
New technology bioengineering immunogenic allows scientists to create artificially, and then to choose the most strong immunogen. If this technology becomes widely available, it will help you to develop vaccines against malaria, HIV, the AIDS virus and from a variety of options other viruses.
Meningococcal disease In very contagious at greatest risk are children, even if they survive after the illness, the life experience difficulties Yves learning, hearing loss and even loss of limbs. Onset occurs so quickly that the antibiotics sometimes don't have time to stop him. This strain can cause death within a few hours, so it is very important in the shortest possible time to develop protection from it, especially for College students, among conscripts and in hostels.